17:07:16 EST Thu 05 Nov 2026
Enter Symbol
or Name
USA
CA



KITS EYECARE LTD.
Symbol KITS
Shares Issued 34,006,241
Close 2026-11-04 C$ 18.92
Market Cap C$ 643,398,080
Recent Sedar+ Documents

ORIGINAL: KITS Eyecare Reports Third Quarter 2026 Results

2026-11-05 16:00 ET - News Release

KITS Eyecare Reports Third Quarter 2026 Results

Canada NewsWire

Record Revenue of $63.7 Million, Increased 21.6% Year-Over-Year
Glasses Revenue Increased 59.3% Year-Over-Year to $11.3 Million
Repeat Revenue Grew 27.8% Year-Over-Year, or 65.6% of Total Revenue
Adjusted EBITDA of $2.9 Million, or 4.6% of Revenue
Sixteenth Consecutive Quarter Reporting Positive Adjusted EBITDA

VANCOUVER, BC, Nov. 5, 2026 /CNW/ -- Kits Eyecare Ltd. (TSX: KITS) ("KITS" or the "Company"), a leading vertically integrated eyecare provider, today announced its financial results for the third quarter ended September 30, 2026.

KITS Logo

Third Quarter 2026 Financial & Operational Highlights

For the third quarter of 2026, compared to the third quarter of 2025:

  • Revenue increased by 21.6% to a record $63.7 million compared to $52.4 million
  • Glasses revenue grew 59.3% to $11.3 million, representing 17.7% of revenue, compared to 13.5%; premium lens upgrades represented 44.8% of glasses revenue
  • Repeat revenue grew 27.8% to a record $41.8 million, or 65.6% of revenue, compared to 62.4% of revenue
  • Gross profit increased by 31.1% to $23.8 million, or 37.4% of revenue, compared to $18.1 million, or 34.6% of revenue
  • Adjusted EBITDA margin was 4.6% of revenue, with $2.9 million of Adjusted EBITDA, compared to 5.5% of revenue, and $2.9 million
  • Net Income was $0.7 million or $0.02 per share (basic), compared to a net income of $1.9 million or $0.06 per share (basic)
  • Operating cash flow of $4.8 million, representing 7.5% of revenue. Closing the quarter with a cash balance of $30.6 million and no debt

Year-to-Date 2026 Financial & Operational Highlights

For the nine months ended September 30, 2026, compared to the nine months ended September 30, 2025:

  • Revenue increased 20.9% (21.6% in constant currency) to $179.6 million compared to $148.6 million
  • Glasses revenue of $33.1 million, increased 57.9% year-over-year
  • Gross profit was $69.5 million or 38.7% of revenue, compared to $53.3 million or 35.8% of revenue
  • Adjusted EBITDA improved by $1.1 million to $10.0 million compared to $8.9 million
  • Net income was $4.1 million compared to net income of $2.8 million

Management Commentary
"The most valuable business in eyecare will be the one customers come back to for both their contacts and their glasses, and this quarter KITS showed it is that business," said Roger Hardy, Co-Founder, Chairman and CEO of KITS. "Revenue grew 21.6% to a record $63.7 million, glasses revenue grew 59.3% to $11.3 million, and contact lens revenue reached a record $52.4 million. Nearly two-thirds of our revenue came from returning customers. Most importantly, gross profit grew 31.1%, nearly one and a half times as fast as revenue. Margins come first, cash flow follows, and earnings follow cash flow. We are delivering the first two. We generated $4.8 million in operating cash flow, funded a meaningful step-up in customer acquisition from our own gross profit, and closed the quarter with $30.6 million in cash, no debt, and our sixteenth consecutive quarter of positive Adjusted EBITDA. Earnings are the next step, and we intend to be measured on it."  

Third Quarter 2026 Financial Results
Revenue for the three months ended September 30, 2026 reached a record $63.7 million, increasing 21.6%, led by glasses revenue that grew 59.3%. The Company generated $4.8 million in cash flow from operations, equal to 7.5% of revenue, and ended the quarter with $30.6 million in cash and no debt. 

The recurring foundation of the business reached new revenue highs. Repeat customers contributed 65.6% of revenue, up from 62.4% in the prior-year period, with repeat revenue growing 27.8% year-over-year to $41.8 million. The Company's 2-year Active Customer base grew 14.1% to a record 1,175,000, and the Autoship subscription program is now a $29.6 million annualized with minimal maintenance cost. 

Glasses led the Company's growth, with revenue up 59.3% to $11.3 million on approximately 144,700 units delivered, up 55.6%. The quality of the growth matched its magnitude: premium lens upgrades represented 44.8% of glasses revenue, 80,850 units were delivered to repeat customers, up 61.7%, and new glasses customers acquired in the quarter generated first-order revenue 63% higher than the comparable prior-year cohort on identical entry pricing, aided by OpticianAI™, the Company's AI-powered fitting engine. Glasses customers acquired in 2026 are generating per-customer first-order revenue that exceeds the multi-year cumulative revenue of cohorts acquired in earlier years.

Contact lens revenue grew 15.7% to a record $52.4 million. Sequentially, contact lens revenue increased $5.1 million, or 10.7%, from the second quarter. Growth was driven by repeat customers, as the Company's large and growing base of returning wearers continued to reorder through KITS.

Gross margin expanded 280 basis points to 37.4%, driven by organic factors: the growing mix of glasses revenue, increased adoption of premium lens upgrades, and disciplined pricing and promotion management.

Fourth Quarter 2026 Outlook
For the fourth quarter of 2026, KITS management expects revenue to be in the range of $64.0 million to $66.0 million, with Adjusted EBITDA as a percentage of revenue between 4.0% and 6.0%. See "Forward-Looking Statements" below for important disclosure with respect to expectations and forward-looking information.

Conference Call
KITS management will host the conference call followed by a question-and-answer period. To access the call instantly, please click here to register your name and phone number via the rapid connect link.

The conference call will also be webcast live with a presentation and available for replay here and via the investor relations section of the Company's website at ir.kits.com.

Date: Thursday, November 5, 2026
Time: 4:30 p.m. Eastern time
Presentation webcast link: https://app.webinar.net/w0MlLRjLYn1
Rapid connect link: https://emportal.ink/4k6ciqa
North American toll-free number: 1-888-510-2154
Local Toronto dial-in number: 1-437-900-0527
Confirmation #: 00220 #

Financial Highlights
The following selected financial information is qualified in its entirety by and should be read conjunction with our consolidated financial statements for the three and nine months ended September 30, 2026 and 2025 and accompanying notes and Management's Discussion and Analysis ("MD&A") which may be viewed on SEDAR+ atwww.sedarplus.ca.


Three Months Ended


Nine Months Ended

Financial and Operating Data

September 30,
2026

(unaudited)


September 30,
2025

(unaudited)


September 30,
2026

(unaudited)


September 30,
2025

(unaudited)













Revenue

$

63,695


$

52,392


$

179,591


$

148,567

Net income

$

672


$

1,937


$

4,103


$

2,846

Net income per share












Basic

$

0.02


$

0.06


$

0.12


$

0.09

Diluted

$

0.02


$

0.06


$

0.12


$

0.08













Non-IFRS Measures (a):












     Constant currency revenue

$

63,142


$

52,392


$

180,672


$

148,567

     EBITDA

$

1,884


$

3,309


$

8,540


$

6,654

     Adjusted EBITDA

$

2,949


$

2,862


$

10,026


$

8,898

     Adjusted EBITDA Margin %


4.6 %



5.5 %



5.6 %



6.0 %













Reconciliation of constant currency revenue












Revenue

$

63,695


$

52,392


$

179,591


$

148,567

Foreign exchange impact


(553)



-



1,081



-

Constant Currency Revenue

$

63,142


$

52,392


$

180,672


$

148,567













Change in constant currency

$

10,750





$

32,105




Change in constant currency %


20.5 %






21.6 %
















Reconciliation of Adjusted EBITDA












Net income for the period

$

672


$

1,937


$

4,103


$

2,846

Add back:












Income taxes


602



698



2,209



1,607

Finance costs – net


90



67



665



366

Depreciation and amortization


520



607



1,563



1,835

EBITDA

$

1,884


$

3,309


$

8,540


$

6,654













Add back












Share-based compensation (b)

$

924


$

97


$

2,802


$

1,010

Exchange loss / (gain)


138



(547)



(1,326)



1,224

One-time costs (c)


3



3



10



10

Adjusted EBITDA

$

2,949


$

2,862


$

10,026


$

8,898













Revenue

$

63,695


$

52,392


$

179,591


$

148,567

Adjusted EBITDA Margin % (d)


4.6 %



5.5 %



5.6 %



6.0 %

Notes:

(a)

Refer to "Non-IFRS Measures and Industry Metrics" section of the MD&A filed on www.sedarplus.ca and below.

(b)

Represents non-cash share-based compensation expense associated with restricted share rights ("RSRs") and options recognized in the period.

(c)

One-time IPO directors' and officers' insurance costs which are expensed over the insurance coverage period.

(d)

Represents Adjusted EBITDA divided by revenue from the same period.

About KITS
KITS (TSX: KITS) is one of the world's fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining the eyecare experience. Designed in Vancouver. Delivered worldwide. For more information on KITS, visit: www.kits.com.

Non-IFRS Financial Measures and Industry Metrics
This press release includes references to certain non-IFRS financial measures such as Constant Currency Revenue, EBITDA, Adjusted EBITDA, Adjusted EBITDA margin percentage and certain industry metrics. These financial measures and industry metrics are employed by the company to measure its operating and economic performance and to assist in business decision-making, as well as providing key performance information to senior management. The company believes that, in addition to conventional measures prepared in accordance with IFRS, certain investors and analysts use this information to evaluate the company's operating and financial performance. These financial measures are not defined under IFRS, nor do they replace or supersede any standardized measure under IFRS. Other companies in our industry may calculate these measures differently than we do, limiting their usefulness as comparative measures. Definitions and reconciliations of non-IFRS measures to the nearest IFRS measure and Industry Metrics can be found in our Management's Discussion and Analysis. Such non- IFRS reconciliations can also be found in this press release under "Financial Highlights".

Forward-Looking Statements
This press release contains forward-looking statements, including statements relating to the execution of our proposed strategy, our operating performance, our expectations and outlook for the fourth quarter of 2026, and prospects for the business. These forward-looking statements generally can be identified by the use of words such as "intend," "believe," "could," "continue," "expect," "estimate," "forecast, "may," "potential," "project," "plan," "would," "will," and other words of similar meaning. Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such a statement. Our business is subject to substantial risks and uncertainties. This forward-looking information and other forward-looking information are based on our opinions, estimates and assumptions in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we currently believe are appropriate and reasonable in the circumstances. Despite a careful process to prepare and review the forward-looking information, there can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct or that our expectations for the fourth quarter of 2026 or generally will be achieved. Certain assumptions in respect of the expansion and enhancement of our fulfillment network, including our optical laboratory for glasses and warehouse facilities; the growth of our business and launch of new technologies; premium lens adoptions and smart eyewear expansion; our ability to drive sales growth; our ability to maintain, enhance, and grow within our addressable market; our ability to drive ongoing development and innovation of our exclusive brands and product categories; our ability to continue directly sourcing from third party suppliers and manufacturers; our ability to retain key personnel; our ability to add, maintain and expand production, distribution and fulfillment capabilities; our ability to continue investing in infrastructure to support our growth; our ability to obtain and maintain existing financing on acceptable terms; currency exchange and interest rates; the impact of competition; the changes and trends in our industry or the global economy; the impact of tariffs and U.S. and international trade actions, policies and reform; and the changes in laws, rules, regulations, and global standards. KITS' risks and uncertainties are discussed in detail in the company's Annual Information Form, filed on SEDAR+ on March 4, 2026. Investors, potential investors, and others should give careful consideration to these risks and uncertainties. We caution investors not to rely on the forward-looking statements contained in this press release when making an investment decision in our securities. The forward-looking statements in this press release speak only as of the date of this release, and we undertake no obligation to update or revise any of these statements, except as required under applicable securities laws. If we do update certain forward-looking information, no inference should be made that we will further update such or other forward-looking Information.

SOURCE KITS Eyecare Ltd.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2026/05/c5566.html

Contact:

For Further Information: Olivia Evans, Director of Corporate Development and Investor Relations, Kits Eyecare Ltd., IR@KITS.com

© 2026 Canjex Publishing Ltd. All rights reserved.